Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | AKT2 | P31751 | 1/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 14/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.34 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035473 | 0.86 | AKT1 (0.48) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL23887230 | 0.85 | AKT1 (0.56) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL31035486 | 0.80 | PIK3CA (0.47) | AKT1AKT2AKT3PIK3CAIDO1 | |
| SCHEMBL31035887 | 0.79 | AKT1 (0.50) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL31035207 | 0.79 | PIK3CA (0.51) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL31035582 | 0.78 | AKT1 (0.43) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL31035343 | 0.77 | PIM1 (0.40) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL23887236 | 0.76 | AKT1 (0.47) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL31035139 | 0.74 | AKT1 (0.46) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL23887318 | 0.74 | PIK3CA (0.60) | AKT1AKT2AKT3PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |